|
|
||||||||
1Department of Kinesiology, College of Health and Human Performance, University of Maryland, College Park; 4Clinical Research Branch, National Institute on Aging, Baltimore, Maryland; and Departments of 2Epidemiology and 3Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
Submitted 21 May 2004 ; accepted in final form 10 September 2004
The human androgen receptor (AR) gene contains a CAG (glutamine) repeat polymorphism in exon 1 that is inversely associated with transcriptional activity of the AR. We studied the association of AR CAG repeat length, fat-free mass (FFM), and testosterone in two independent cohorts: 294 Caucasian men, aged 5593 yr, from the Study of Osteoporotic Risk in Men (STORM), and 202 Caucasian volunteers (112 men and 90 women), aged 1990 yr, from the Baltimore Longitudinal Study of Aging (BLSA). Subjects were genotyped to determine the number of AR CAG repeats and grouped as carrying either <22 or
22 repeats. Whole body soft tissue composition was measured by dual-energy X-ray absorptiometry. Men with greater CAG repeat number exhibited significantly greater total FFM than those with fewer CAG repeats in both cohorts (STORM: 59.2 ± 0.3 vs. 58.0 ± 0.4 kg, P = 0.02; BLSA: 57.2 ± 1.1 vs. 53.8 ± 1.1 kg, P = 0.04). Similar results were observed for total FFM normalized to height. No differences were seen in women in the BLSA cohort. In the BLSA cohort, serum testosterone levels were higher in subjects with greater repeat number (P = 0.003). This same pattern approached significance in the STORM cohort (P = 0.07). In conclusion, the androgen receptor CAG repeat polymorphism is associated with FFM in men in two independent cohorts. Additional studies are needed to confirm this observation and to clarify the mechanisms involved.
body composition; genetics; muscle mass; muscle strength; testosterone
This article has been cited by other articles:
![]() |
S. Walsh, B. K. Kelsey, T. J. Angelopoulos, P. M. Clarkson, P. M. Gordon, N. M. Moyna, P. S. Visich, R. F. Zoeller, R. L. Seip, S. Bilbie, et al. CNTF 1357 G -> A polymorphism and the muscle strength response to resistance training J Appl Physiol, October 1, 2009; 107(4): 1235 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Eriksson, M. Lorentzon, L. Vandenput, F. Labrie, M. Lindersson, A.-C. Syvanen, E. S. Orwoll, S. R. Cummings, J. M. Zmuda, O. Ljunggren, et al. Genetic Variations in Sex Steroid-Related Genes as Predictors of Serum Estrogen Levels in Men J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 1033 - 1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. T. Huhtaniemi, S. R. Pye, K. L. Limer, W. Thomson, T. W. O'Neill, H. Platt, D. Payne, S. L. John, M. Jiang, S. Boonen, et al. Increased Estrogen Rather Than Decreased Androgen Action Is Associated with Longer Androgen Receptor CAG Repeats J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 277 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
R D Stanworth, D Kapoor, K S Channer, and T H Jones Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes Eur. J. Endocrinol., December 1, 2008; 159(6): 739 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Walsh, D. Liu, E. J. Metter, L. Ferrucci, and S. M. Roth ACTN3 genotype is associated with muscle phenotypes in women across the adult age span J Appl Physiol, November 1, 2008; 105(5): 1486 - 1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Shah, H. J. Antoine, M. Pall, K. D. Taylor, R. Azziz, and M. O. Goodarzi Association of Androgen Receptor CAG Repeat Polymorphism and Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1939 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Prior, S. M. Roth, X. Wang, C. Kammerer, I. Miljkovic-Gacic, C. H. Bunker, V. W. Wheeler, A. L. Patrick, and J. M. Zmuda Genetic and environmental influences on skeletal muscle phenotypes as a function of age and sex in large, multigenerational families of African heritage J Appl Physiol, October 1, 2007; 103(4): 1121 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Crabbe, V. Bogaert, D. De Bacquer, S. Goemaere, H. Zmierczak, and J. M. Kaufman Part of the Interindividual Variation in Serum Testosterone Levels in Healthy Men Reflects Differences in Androgen Sensitivity and Feedback Set Point: Contribution of the Androgen Receptor Polyglutamine Tract Polymorphism J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3604 - 3610. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Walsh, E. J. Metter, L. Ferrucci, and S. M. Roth Activin-type II receptor B (ACVR2B) and follistatin haplotype associations with muscle mass and strength in humans J Appl Physiol, June 1, 2007; 102(6): 2142 - 2148. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Lapauw, S Goemaere, P Crabbe, J M Kaufman, and J B Ruige Is the effect of testosterone on body composition modulated by the androgen receptor gene CAG repeat polymorphism in elderly men? Eur. J. Endocrinol., March 1, 2007; 156(3): 395 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
A M Solomon and P M G Bouloux Modifying muscle mass - the endocrine perspective. J. Endocrinol., November 1, 2006; 191(2): 349 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Albertelli, A. Scheller, M. Brogley, and D. M. Robins Replacing the Mouse Androgen Receptor with Human Alleles Demonstrates Glutamine Tract Length-Dependent Effects on Physiology and Tumorigenesis in Mice Mol. Endocrinol., June 1, 2006; 20(6): 1248 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Clarkson, J. M. Devaney, H. Gordish-Dressman, P. D. Thompson, M. J. Hubal, M. Urso, T. B. Price, T. J. Angelopoulos, P. M. Gordon, N. M. Moyna, et al. ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women J Appl Physiol, July 1, 2005; 99(1): 154 - 163. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |